Bayer Names Bill Anderson as CEO
Bill Anderson, former CEO of Roche’s pharmaceutical division, will take over as CEO of Bayer on June 1, 2023.
Bayer AG announced on Feb. 8, 2023 that Bill Anderson will take over as CEO on June 1, 2023. Anderson, the former CEO of Roche’s pharmaceutical division, has also held senior leadership positions with Biogen and Genentech.
“We are very excited to welcome Bill Anderson as the new CEO of Bayer. Bill has an outstanding track record of building strong product pipelines and turning biotech breakthroughs into products,” said Norbert Winkeljohann, chairman, Supervisory Board, Bayer AG, in a company press release. “Beyond that, he is a truly transformational leader who creates a culture that propels innovation, boosts productivity and performance, and allows people to thrive.”
“Bayer is an innovative company that is already delivering tremendous benefits for the nutrition, health and environmental protection of the world,” said Anderson in the release. “I look forward to working with the people of Bayer to accelerate innovation, increase performance, advance sustainability and unleash the full potential of the company.”
In addition to this appointment, Anderson is also slated to join Bayer’s board of management on April 1, 2023. Current CEO Werner Baumann is expected to aid in the transition through the end of May 2023.
Source: Bayer
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
